ténofovir alafénamide
RxNorm 1721603· ATC J05AF13· tenofovir alafenamide
KR · 한국Produits en Corée (6)
- 테노포벨에이정(테노포비르알라페나미드숙신산염)(주)종근당
- 테노포벨에이정(테노포비르알라페나미드숙신산염)(주)종근당
- 베믈리아정(테노포비르알라페나미드시트르산염)동아에스티(주)
- 베믈리아정(테노포비르알라페나미드시트르산염)동아에스티(주)
- 테카비어디정(테노포비르알라페나미드)제일약품(주)
- 테카비어디정(테노포비르알라페나미드)제일약품(주)
U.S. drug label (openFDA)
VEMLIDY — indications, dosage, warnings, adverse events →Chimie (PubChem)
- Formule moléculaire
- C21H29N6O5P
- Masse moléculaire
- 476.5 g/mol
- Nom IUPAC
- propan-2-yl (2S)-2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-phenoxyphosphoryl]amino]propanoate
- InChIKey
- LDEKQSIMHVQZJK-CAQYMETFSA-N